Transgene Biotek Limited. Press Release Jul 23 2026

Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby infom you that a meeting of the Board of Directors of Transgene Biotek Limited is scheduled to be held on Friday, August 07, 2026, inter alia, to consider and approve the following matters: 1. To consider and approve the n-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2026.2. To consider and approve the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30h June 2026.3. To consider and approve seeking an extension of time for holding the Annual General Meeting (AGM) of the Company for the Financial Year 2025-26.4. To consider and approve the appointment of the internal auditor of the Company for financial year 2026-27.5. To transact such other business as may be required.

View Attachment